CIK 0001818794 · Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364883909
- Phone
- (781) 786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $40,000
- in 1 filing
- Open-market sales, last 90 days
- $247,777
- in 3 filings, $248K under 10b5-1 plans
Net −$207,777. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-28 | Atlas Venture Fund XI, L.P. 10% owner | Sale 10b5-1 | −360 | $25.25 | $9K | 1,488,126 |
| 2024-02-28 | Atlas Venture Fund XI, L.P. 10% owner | Sale 10b5-1 | −13,109 | $24.83 | $325K | 864,697 |
| 2024-02-28 | Atlas Venture Fund XI, L.P. 10% owner | Sale 10b5-1 | −210 | $25.25 | $5K | 864,487 |
| 2024-02-28 | Farwell Wildon Chief Medical Officer | Sale 10b5-1 | −407 | $25.00 | $10K | 163,096 |
| 2024-02-27 | Rhodes Jason P Director | Sale 10b5-1 | −272,923 | $24.38 | $6.7M | 5,878,544 |
| 2024-02-27 | Rhodes Jason P Director | Sale 10b5-1 | −25,779 | $24.68 | $636K | 5,852,765 |
| 2024-02-27 | Rhodes Jason P Director | Sale 10b5-1 | −40,455 | $24.38 | $986K | 1,514,874 |
| 2024-02-27 | Rhodes Jason P Director | Sale 10b5-1 | −3,821 | $24.68 | $94K | 1,511,053 |
| 2024-02-27 | Rhodes Jason P Director | Sale 10b5-1 | −23,505 | $24.38 | $573K | 880,022 |
| 2024-02-27 | Rhodes Jason P Director | Sale 10b5-1 | −2,216 | $24.68 | $55K | 877,806 |
| 2024-02-27 | Atlas Venture Fund XI, L.P. 10% owner | Sale 10b5-1 | −272,923 | $24.38 | $6.7M | 5,878,544 |
| 2024-02-27 | Atlas Venture Fund XI, L.P. 10% owner | Sale 10b5-1 | −25,779 | $24.68 | $636K | 5,852,765 |
| 2024-02-27 | Atlas Venture Fund XI, L.P. 10% owner | Sale 10b5-1 | −40,455 | $24.38 | $986K | 1,514,874 |
| 2024-02-27 | Atlas Venture Fund XI, L.P. 10% owner | Sale 10b5-1 | −3,821 | $24.68 | $94K | 1,511,053 |
| 2024-02-27 | Atlas Venture Fund XI, L.P. 10% owner | Sale 10b5-1 | −23,505 | $24.38 | $573K | 880,022 |
| 2024-02-27 | Atlas Venture Fund XI, L.P. 10% owner | Sale 10b5-1 | −2,216 | $24.68 | $55K | 877,806 |
| 2024-02-26 | Rhodes Jason P Director | Sale 10b5-1 | −136,312 | $23.59 | $3.2M | 6,216,250 |
| 2024-02-26 | Rhodes Jason P Director | Sale 10b5-1 | −64,783 | $23.98 | $1.6M | 6,151,467 |
| 2024-02-26 | Rhodes Jason P Director | Sale 10b5-1 | −20,205 | $23.59 | $477K | 1,564,932 |
| 2024-02-26 | Rhodes Jason P Director | Sale 10b5-1 | −9,603 | $23.98 | $230K | 1,555,329 |
Page 24 of 29 · 561 trades